1. Home
  2. NUVL vs URBN Comparison

NUVL vs URBN Comparison

Compare NUVL & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$101.45

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Urban Outfitters Inc.

URBN

Urban Outfitters Inc.

HOLD

Current Price

$75.78

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
URBN
Founded
2017
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.4B
IPO Year
2021
1993

Fundamental Metrics

Financial Performance
Metric
NUVL
URBN
Price
$101.45
$75.78
Analyst Decision
Strong Buy
Buy
Analyst Count
15
12
Target Price
$135.00
$87.18
AVG Volume (30 Days)
485.1K
1.8M
Earning Date
10-30-2025
11-25-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
51.24
EPS
N/A
5.28
Revenue
N/A
$5,999,726,000.00
Revenue This Year
N/A
$12.13
Revenue Next Year
N/A
$7.95
P/E Ratio
N/A
$14.21
Revenue Growth
N/A
11.09
52 Week Low
$55.54
$41.89
52 Week High
$112.88
$83.94

Technical Indicators

Market Signals
Indicator
NUVL
URBN
Relative Strength Index (RSI) 45.84 49.40
Support Level $99.38 $74.63
Resistance Level $106.65 $83.88
Average True Range (ATR) 2.78 2.14
MACD -0.75 -1.07
Stochastic Oscillator 24.04 12.35

Price Performance

Historical Comparison
NUVL
URBN

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About URBN Urban Outfitters Inc.

Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.

Share on Social Networks: